323 Effectiveness of Low Intensity Focused Ultrasound in Improving Drug Delivery and Functional Recovery in Chronic Spinal Cord Injury

View at publisher Summarise with VIRAT
Authors: Abdul Karim Ghaith, Taha Khalilullah, Lansaol Yang, F. M. Moinuddin, Ashis Dhar, Daniel Lubelski, Nicholas Theodore, Amir Manbachi, Shigao Chen, Anthony J. Windebank
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Chronic spinal cord injury (cSCI) remains a major clinical challenge due to limited intrinsic repair and poor efficacy of pharmacologic or regenerative interventions, largely attributed to restricted permeability of the blood-spinal cord barrier (BSCB). Low intensity focused ultrasound (LIFU) has emerged as a non-invasive technique capable of transiently and safely disrupting the BSCB. METHODS: The study was conducted in two experimental arms. in the first arm, eight female Sprague-Dawley rats were randomized into LIFU-treated (n = 4) or control (n = 4) groups to assess BSCB permeability. All rats underwent T9–T11 laminectomy. the LIFU parameters were: frequency = 551.5 kHz, burst duration = 10 ms, pulse repetition frequency = 2 Hz, total sonication = 2 minutes. Rats received intravenous Definity® microbubbles immediately prior to sonication. Subsequently, Evans Blue (EB) dye was administered to assess BSCB permeability via spectrophotometry of harvested spinal cord tissue. in the second arm, 18 rats with T9–T11 contusion injuries were assigned to one of three groups (n = 6 per group): (1) LIFU + UCMSC, (2) UCMSC-only, and (3) saline control. UCMSCs (1 × 106 cells) were administered intravenously 3 weeks post-injury. Rats receiving LIFU + UCMSC were sonicated at the same parameters described above immediately prior to cell infusion. Functional recovery was tracked using the Basso, Beattie, and Bresnahan (BBB) locomotor scale over 6 weeks. Histological assessments included myelinated axon quantification and immunohistochemistry for GFAP to evaluate glial scarring. RESULTS: LIFU significantly enhanced BSCB permeability. Spectrophotometric analysis demonstrated that EB concentrations in spinal tissue were significantly higher in the LIFU + EB group (0.2688 µg/mL) compared to the EB-only group (0.0928 µg/mL; p < 0.001). Ultra-harmonic emissions and prominent EB staining were observed only in sonicated animals, confirming successful mechanical disruption of the BSCB. in the therapeutic efficacy arm, rats receiving LIFU + UCMSC exhibited significantly improved functional recovery, with BBB scores of 14.6 ± 1.9 at 6 weeks compared to 10.1 ± 1.7 in the control group and 12.0 ± 1.4 in the UCMSC-only group (p < 0.001 for LIFU+UCMSC vs. control; p < 0.05 vs. UCMSC-only). Histological analysis revealed significantly increased densities of myelinated axons and reduced GFAP-positive glial scarring in the LIFU+UCMSC group, suggesting enhanced regenerative repair. CONCLUSIONS: This study demonstrates that low intensity focused ultrasound effectively and non-invasively disrupts the blood-spinal cord barrier in a chronic SCI model, significantly enhancing the delivery of both small molecules and cell-based therapeutics. the combination of LIFU with UCMSCs yielded superior motor recovery and histological repair compared to stem cell therapy alone, underscoring the translational potential of LIFU as an adjunctive platform for targeted therapeutic delivery in chronic spinal cord injury. Future investigations in larger animal models and clinical translation are warranted.

Fields of Study & Subjects

Ultrasound and Hyperthermia Applications Spinal Cord Injury Research Microbial Inactivation Methods

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
83–84
Publication date
26 March 2026
Language
EN